Forensic Analysis · Technology / Software · as of Jun 27, 2026
SILICON LABORATORIES INC. (SLAB)
A forensic read on SILICON LABORATORIES INC. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
C · Mixed — selective
Forensic grade
Safe
Financial health
11.3
Altman Z-score
Clean
Earnings quality
3
Forensic signals
-4.7%
ROE
$7.2B
Market cap
SILICON LABORATORIES INC. earns a C (Mixed — selective) forensic quality grade, and its Altman Z-score is 11.3, placing it in the Safe zone. 3 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
-7%Return on invested capital.Return on invested capital is -7% and slipping from 6% — well below its ~10% cost of capital, so reinvested dollars may be destroying value, not building it.
10% of revStock-based comp load.Stock-based compensation ran 10% of revenue and 122% of free cash flow in FY2026 — about $2.45 per diluted share. Heavy — a large slice of 'free cash flow' is really being paid out in stock, so the true owner cash per share is well below the headline.
stoppedShareholder returns — halted.Capital returns have STOPPED — $16,000 of buybacks + dividends in FY2024, but ~$0 in FY2026. A halt usually means the company is conserving cash; understand why before reading it as neutral.
Key fundamentals
Net Margin-8.3%
Debt / Equity0.08x
Free Cash Flow$65.8M
Latest Revenue$784.8M
Return on Equity-5.9%
Revenue Growth YoY+34.3%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on SILICON LABORATORIES INC.:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about SLAB's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown